Skip to search formSkip to main contentSkip to account menu

bazedoxifene acetate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2013
2013
OBJECTIVE Concerns of breast cancer risk in postmenopausal women taking combined estrogen + progestin therapy have generated… 
2011
2011
A Multidisciplinary National Panel of Experts in the management of Menopause and Postmenopausal Osteoporosis was created to… 
2010
2010
Bazedoxifene acetate (BZA), a novel selective estrogen receptor modulator, is currently being developed for the prevention and… 
Review
2009
Review
2009
Postmenopausal osteoporosis is an increasing worldwide health concern affecting an estimated 200 million individuals. Despite a… 
2005
2005
The present invention is a solid dispersion of bazedoxifene acetate, compositions containing them, and their preparation, and… 
2005
2005
FIELD: medicine. SUBSTANCE: invention refers to pharmacology. A solid pharmaceutical dispersion contains bazedoxifene acetate… 
2002
2002
In order to develop a new tissue selective estrogen with superior preclinical pharmacology, a multifaceted approach to screening…